Subscribe to Updates in Healthcare

RSS By Email

RSS By RSS

Add to Google Reader or Homepage

Subscribe in Bloglines


The Expertise Imperative and Compliance Technology
Access to a diverse array of specialized expert inputs drives superior decisions in every organizational context: within corporations, by investors and consultancies, and within nonprofits. When decision makers are confident of their decision inputs, they can respond more quickly and creatively to challenges and opportunities.Learn more about GLG's Compliance Framework


This page may include content provided by Council Members, your access to which is subject to the Terms of Use.
Find Out More

GLG News by Managed Care Experts

Articles with lock require a subscription to GLG News | Request a free trial
June 4, 2008
When CMS put objectives in the blender, providers get the mash
Analysis of: CMS ANNOUNCES DEMONSTRATION TO ENCOURAGE GREATER COLLABORATION AND IMPROVE QUALITY USING BUNDLED HOSPITAL PAYMENTS | www.cms.hhs.gov
Author: GLG Expert Contributor
CMS has the objective of keeping their costs down, increasing quality, protecting the Stark laws against physician referrals, and guarding against beneficiaries being enticed to receive more services than necessary.  CMS threw all these objectives into the ACE demonstration project.  The problems...
May 15, 2008
Reverse Payments for PHRMA smell fishy
Analysis of: US trade agency wants to end deals delaying generics | www.reuters.com
Author: Bruce Goldberg, President, Pharmacy Express Services, Inc.
Our FTC has gone on record once again stating that the so called "Phrma reverse payments" to generic manufacturers breach antitrust regulations. Delaying competition by simply paying off another supplier, leads to higher prices for me, you, and our families.  My grandpa used to call this stuff...
May 8, 2008
Ranking Doctors and Hospitals
Analysis of: Physician report card validity | physiciansnews.com
Author: GLG Expert Contributor
Ranking doctors and hospitals will certainly move the most profitable patients able to afford commercial health insurance AND travel.  Medical Providers who help set their (local) standards to affect real outcomes reporting regular consumers can understand will increase their market share. ...
May 6, 2008
Government Cuts in Funding for DXA in Physicians' Offices May Lead to Difficulties for Rural Patients
Analysis of: DXA Reimbursement Reductions: Implications for Quality Osteoporosis Care, Marjorie Luckey, MD and Roberta Biegel (Washington, DC: National Osteoporosis Foundation, Winter 2005) | osteoporosisblogger.com
Author: William Fink, President, Managed Care Pharmacy Consultants, Inc
It is well known that millions of people in the US suffer from osteoporosis which leads directly to debilitating fractures.   Early diagnosis of osteoporosis and low bone mass will help prevent chronic pain and loss of independence.  Once diagnosed, treatment is readily available and...
April 30, 2008
FDA: Chinese Manufacturer of Tainted Heparin Involved in Fraud.
Analysis of: UPDATE: FDA Head Sees Economic Fraud Behind Tainted Heparin | www.reuters.com
Author: Joe Atkins, Chief Executive Officer, Medical Concepts & Innovations
First, and foremost, the only working link for this article can be found at: http://www.reuters.com/article/domesticNews/idUSWAT00934620080415?feedType=RSS&feedName=domesticNews Although there is no proof offered in the article to substantiate the suggestion of fraud, there is enough circumstantial...
Robert ForsterApril 30, 2008
The Human Genome will promote genetic counciling chaos and misinformation
Analysis of: Experts see boost to genetic testing from US bill | www.reuters.com
Author: Robert Forster, Healthcare Consultant, Robert Forster, MD
There are many reasons why the commercialization of human genome "information" will be ABSOLUTE CHAOS AND COST.  The three most prominent are the following:   1. Physician education is almost devoid of practical genomic teachings except for Diabetes and lipid disorders.   2. ...
April 30, 2008
FDA Fees Must Be Increased to Fund Inspection of Chinese Products.
Analysis of: FDA fees eyed to boost food, drug safety | www.usatoday.com
Author: Joe Atkins, Chief Executive Officer, Medical Concepts & Innovations
One only has to read about the Heparin debacle, which has killed, at least, 81 Americans, to realize that there is a serious issue with the quality of medicines produced in China.  Manufacturing of medical food and consumer goods in China is growing at such a rate, the Chinese government has neither...
April 30, 2008
Who to Blame for Waste in the Medical Industry? Who's on First?
Analysis of: The Price of Excess: Identifying Waste in Healthcare Spending | blogs.wsj.com
Author: Joe Atkins, Chief Executive Officer, Medical Concepts & Innovations
It's easy to point fingers of blame and this article does that, very well.  According to the "annalysis" everybody is to blame.  And, they're right, everyone is to blame, but where the article fails is the authoris inability to point out a real solution to the problem of wasted dollars spent...
April 30, 2008
Anemia Drugs Have Been Abused for Profit!
Analysis of: WellPoint likely to follow FDA on anemia drugs | www.reuters.com
Author: Joe Atkins, Chief Executive Officer, Medical Concepts & Innovations
Over the last year, it has become clear that the over-use of anemia drugs for cancer and renal failure has become a problem.  The reason can be sumed up in one word, which is profit.
Frederic GoldsteinApril 29, 2008
Genetic Testing Will Move to Mainstream Acceptance
Analysis of: Experts see boost to genetic testing from US bill | www.reuters.com
Author: Frederic Goldstein, President and Chief Operating Officer, U.S. Preventive Medicine, Inc.
The passage of this bill by the Senate and the likely passage by the house are both good for consumers as well as the companies that conduct genetic testing.

Previous Page : 1 2 3 4 5 6 7 8 9 10 11 12 13 Next31 to 40 of 288

GLG News: What Experts Think Is Important





Analytics


Generated at 2008-12-02T01:45:17.000